Ellanse and Radiesse in Korea: How Biostimulatory Fillers Differ from Hyaluronic Acid

Biostimulators add volume first, then build collagen over two to three months. Photo: ibnu ihza / Unsplash

Ellanse and Radiesse in Korea are biostimulatory fillers: injectables that add immediate volume and then prompt the skin to build its own collagen, rather than simply holding water in place the way a hyaluronic acid product does.

That distinction changes almost everything a prospective patient should weigh. Biostimulators tend to last longer than standard HA fillers, behave differently as they fade, and cannot be dissolved on demand. Korean clinics offer both products widely, often alongside hyperdilution protocols that use them as skin-quality treatments rather than contouring agents. This article covers what each product is made of, how the two differ in onset and longevity, where they are typically placed, the reversibility problem, nodule risk, how Korean pricing and course structures usually work, and who is a poor candidate. It is general information and not medical advice.

What Biostimulatory Fillers Actually Do

A conventional hyaluronic acid filler works mechanically. The gel occupies space, binds water, and is gradually broken down by the body, after which the correction disappears. A biostimulatory filler works in two stages. The carrier gel provides an initial lift that behaves much like an HA product for the first weeks. As that carrier resorbs, the suspended particles or polymer remain and provoke a controlled foreign-body response, recruiting fibroblasts that deposit new collagen around the material.

The practical consequence is a delayed and gradual result. Patients who judge the outcome at week two are usually looking at carrier volume alone. The collagen component typically becomes apparent over roughly two to three months. Reported longevity in the published literature is generally longer than for standard HA fillers, though individual variation is substantial and figures quoted in marketing material should be treated as averages rather than promises.

Ellanse: Polycaprolactone and the Series System

Ellanse suspends polycaprolactone (PCL) microspheres in a carboxymethylcellulose carrier. PCL is a resorbable polyester already familiar in medicine from sutures and implantable devices. Its defining feature in aesthetics is that the duration can be engineered: by altering the molecular weight and chain structure of the spheres, the manufacturer produces variants with different resorption timelines, marketed in Korea as a short, medium and longer-duration series.

This tunability is the main reason some Korean injectors prefer it. A patient uncertain about a chin or temple correction can begin with the shortest variant and accept that the result will fade sooner. Someone who has had the same correction repeatedly and is confident in the plan may choose a longer variant and reduce visit frequency.

The trade-off is that a longer-duration product is also a longer-lasting mistake. If placement is too superficial or the volume is excessive, the problem persists for the product's full lifespan. Several Korean surgeons therefore restrict longer variants to patients they have already treated at least once.

Radiesse: Calcium Hydroxylapatite and Hyperdilution

Radiesse suspends calcium hydroxylapatite (CaHA) microspheres, a mineral chemically similar to the inorganic component of bone, in a carboxymethylcellulose gel. Undiluted, it is a relatively firm product used where structural support is wanted — jawline definition, chin projection, and the bony framework of the midface.

The more distinctive Korean use is hyperdilution. The product is mixed with saline or lidocaine at ratios well beyond the label, converting it from a volumiser into a thin biostimulant spread across a broad area. Injected in that form into the neck, decolletage, upper arms or the dorsum of the hands, it is used to address crepey texture and laxity rather than to add contour. Clinical reports on hyperdiluted CaHA for skin quality are encouraging but mostly small in scale, and this remains an off-label application. Patients should ask directly whether a quoted treatment is a contouring injection or a hyperdilution course, because the two have different goals, different session counts and different costs.

How They Differ from Hyaluronic Acid Fillers

Reversibility Is the Decisive Difference

Hyaluronic acid filler can be dissolved with hyaluronidase. That safety valve matters for correcting an asymmetry, reducing an overfilled area, and above all for managing a vascular occlusion, where rapid dissolution of the obstructing gel is the standard emergency response.

Neither PCL nor CaHA has an equivalent antidote. A visible nodule may be addressed with steroid injection, subcision, massage or, in persistent cases, surgical excision, but there is no reliable way to simply remove the product. This is the single most important reason to treat a biostimulator as a more consequential decision than an HA filler, and to be conservative with volume and with the choice of injector.

Onset, Duration and How the Result Fades

HA filler looks finished within days. Biostimulators look modest early, improve over two to three months, then decline slowly. Because the collagen component fades gradually rather than as a discrete loss of gel, patients often describe the endpoint as softer and less abrupt than an HA filler wearing off. That gradual decline also makes it harder to judge when a repeat session is due, which is why interval planning should be set with the clinic rather than by self-assessment.

Where Each Is Typically Placed

Both products are generally deposited deep — supraperiosteally or in deep subcutaneous planes — where the overlying tissue masks any irregularity. Common targets include the temples, the lateral cheek, the chin, the pre-jowl area and the jawline.

Both are usually avoided in the lips, where the mobility and thin mucosa of the area make nodule formation likely. Most injectors also avoid the tear trough with biostimulators, preferring a soft, dissolvable HA product in a region where lumps are highly visible and the vascular anatomy is unforgiving. If a Korean clinic proposes a biostimulator in the lips or under the eyes, the reasoning deserves explicit discussion before consent.

Unlike hyaluronic acid, these products cannot be dissolved on demand. Photo: ibnu ihza / Unsplash

Risks, Nodules and Why Technique Matters

The risks shared with all injectables include bruising, swelling, infection, asymmetry and, rarely, vascular occlusion with the potential for skin necrosis or visual compromise. The risk more specific to biostimulators is late nodule formation, where a firm lump appears weeks or months after an apparently uneventful session, typically linked to superficial placement, excessive volume in one site, or injection into a highly mobile area.

Because no dissolving agent exists, prevention carries more weight than correction. Reasonable questions for a consultation are how many syringes are planned, in which anatomical plane, whether the injector uses a cannula or needle in that region, and what the clinic's documented protocol is if a nodule or a vascular event occurs. A clinic that cannot answer the last question clearly is answer enough.

What Korean Clinics Typically Charge and How Courses Are Structured

Pricing in Seoul varies widely by district, clinic tier and whether the injector is a board-certified specialist. Rather than relying on an advertised figure, patients should establish three things in writing: the price per syringe or per vial, how many units the proposed plan requires in total, and whether follow-up visits and any touch-up are included or billed separately.

Hyperdilution courses are usually quoted as a package of several sessions spaced weeks apart, so a single-session price is not comparable to a contouring quote. Package deals that bundle a biostimulator with unrelated treatments can obscure the per-unit cost; asking for the itemised price of the injectable alone is a reasonable request and a useful test of transparency.

Who Is Not a Reasonable Candidate

Biostimulators are generally avoided in patients who are pregnant or breastfeeding, who have an active infection at or near the planned site, or who have a known hypersensitivity to a component of the product. A history of autoimmune or granulomatous disease, or of nodule formation after previous injectables, warrants a cautious discussion and often a different approach.

Patients who want a result they can reverse if they dislike it are better served by hyaluronic acid. Patients seeking a dramatic change in facial structure are usually better served by surgery, since the volume of biostimulator required to imitate a skeletal change tends to create the nodule risk described above.

Frequently Asked Questions

Can Ellanse or Radiesse be dissolved if I do not like the result?

No. Unlike hyaluronic acid filler, neither has a dissolving agent. Management of an unwanted result relies on steroid injection, subcision, time, or in persistent cases surgical removal. This is why conservative volumes and an experienced injector matter more with biostimulators than with HA.

How long do the results last?

Published reports and manufacturer data generally indicate longer duration than standard HA fillers, with Ellanse variants differing from each other by design. Actual duration varies with the individual, the site, the volume used and metabolism, so any single figure should be read as an average rather than an expected outcome.

Can I have HA filler and a biostimulator at the same time?

Many Korean injectors do combine them, using HA where softness or reversibility is wanted and a biostimulator for deeper support. Whether to do so in one session or stage them apart is a clinical judgement, and staging makes it easier to attribute any complication to a specific product.

Is hyperdiluted Radiesse for the neck and hands evidence-based?

It is a recognised and widely practised off-label use, supported mainly by small studies and clinical experience rather than large trials. It is reasonable to ask the clinic what outcome range it has observed and to expect a course of sessions rather than a single treatment.

How do I verify the product is genuine?

Ask to see the sealed packaging and the Korean import or approval labelling before injection, and ask which specific variant is being used. Counterfeit and parallel-import injectables are a documented concern in aesthetic medicine generally, and a clinic should have no difficulty showing the box.

Planning a Biostimulator Treatment in Korea

The decision that matters is not Ellanse versus Radiesse but whether a non-reversible injectable suits your goal at all. If the answer is yes, the next priorities are an injector who treats the planned area routinely, a written plan specifying product, variant, volume and plane, and a clear complication protocol.

If you are comparing clinics in Seoul for a biostimulator consultation, review surgeon credentials and specialty certification before price, and bring the questions above to the appointment. Sources consulted for general procedural and safety context include the Korean Society of Plastic and Reconstructive Surgeons, the Korean Medical Association and peer-reviewed literature indexed in PubMed.